IL272767A - Composition comprising wharton's jelly, method for preparing same and uses thereof - Google Patents

Composition comprising wharton's jelly, method for preparing same and uses thereof

Info

Publication number
IL272767A
IL272767A IL272767A IL27276720A IL272767A IL 272767 A IL272767 A IL 272767A IL 272767 A IL272767 A IL 272767A IL 27276720 A IL27276720 A IL 27276720A IL 272767 A IL272767 A IL 272767A
Authority
IL
Israel
Prior art keywords
wharton
jelly
composition
preparing same
preparing
Prior art date
Application number
IL272767A
Other languages
Hebrew (he)
Other versions
IL272767B2 (en
IL272767B1 (en
Original Assignee
Tbf Genie Tissulaire Tbf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tbf Genie Tissulaire Tbf filed Critical Tbf Genie Tissulaire Tbf
Publication of IL272767A publication Critical patent/IL272767A/en
Publication of IL272767B1 publication Critical patent/IL272767B1/en
Publication of IL272767B2 publication Critical patent/IL272767B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00—Processes of additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Medicinal Preparation (AREA)
IL272767A 2017-08-23 2018-08-23 Composition comprising wharton's jelly, method for preparing same and uses thereof IL272767B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1757828A FR3070262B1 (en) 2017-08-23 2017-08-23 COMPOSITION CONSISTING OF WHARTON'S JELLY, METHOD OF PREPARATION AND USES
PCT/EP2018/072829 WO2019038411A1 (en) 2017-08-23 2018-08-23 Composition comprising wharton's jelly, method for preparing same and uses thereof

Publications (3)

Publication Number Publication Date
IL272767A true IL272767A (en) 2020-10-29
IL272767B1 IL272767B1 (en) 2023-09-01
IL272767B2 IL272767B2 (en) 2024-01-01

Family

ID=60765763

Family Applications (1)

Application Number Title Priority Date Filing Date
IL272767A IL272767B2 (en) 2017-08-23 2018-08-23 Composition comprising wharton's jelly, method for preparing same and uses thereof

Country Status (4)

Country Link
EP (1) EP3672607B1 (en)
FR (1) FR3070262B1 (en)
IL (1) IL272767B2 (en)
WO (1) WO2019038411A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3096888B1 (en) 2019-06-04 2021-06-25 Tbf Genie Tissulaire BIOLOGICAL LENS INCLUDING AN AMNIOTIC MEMBRANE
WO2020245324A1 (en) 2019-06-04 2020-12-10 Tbf Genie Tissulaire (Tbf) Biological lens comprising an amniotic membrane
WO2022159789A1 (en) * 2021-01-25 2022-07-28 Biostem Technologies, Inc. Two-part clotting composition and methods of making and using thereof
EP4066866A1 (en) 2021-03-29 2022-10-05 Université De Reims Champagne-Ardenne DECELLULARISED WHARTONýS JELLY - METHOD FOR OBTAINING, BIOMATERIAL, COMPOSITIONS AND ASSOCIATED PRODUCTS
FR3124696A1 (en) 2021-06-30 2023-01-06 Tbf - Genie Tissulaire Biological material impregnated with lipid vesicles
WO2023164799A1 (en) * 2022-03-01 2023-09-07 傅毓秀 Wharton's jelly product capable of promoting osteogenesis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620938B3 (en) 1987-09-30 1990-01-05 Bontemps Raymond NEW DEVICE FOR STORING FROZEN COSMETIC SUBSTANCES
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
FR2949042B1 (en) * 2009-08-11 2011-11-04 Tbf Genie Tissulaire PROCESS FOR TREATING CARTILAGE-LIKE TISSUE
EP2892577B1 (en) * 2012-09-04 2019-01-30 Anthrogenesis Corporation Methods of tissue generation
KR101515369B1 (en) * 2013-01-11 2015-04-30 (주)차바이오텍 Methods for Culturing Endothelial Progenitor Cells Derived from Human Umbilical Cord Bloods and Compositions for Preventing or Treating Ischemic Diseases Comprising Endothelial Progenitor Cells Derived from Human Umbilical Cord Bloods
US11903612B2 (en) * 2013-11-04 2024-02-20 University Of Iowa Research Foundation Bioprinter and methods of using same
AU2015264025A1 (en) 2014-05-21 2016-12-01 Mimedx Group, Inc. Micronized Wharton's jelly
TW201603818A (en) 2014-06-03 2016-02-01 組織科技股份有限公司 Compositions and methods
FR3047899A1 (en) * 2016-02-18 2017-08-25 Tbf - Genie Tissulaire Et Par Abreviation Tbf PROCESS FOR PREPARING AN ALLOGRAFT MATERIAL, PRODUCT OBTAINED, AND USES THEREOF

Also Published As

Publication number Publication date
FR3070262B1 (en) 2020-10-16
IL272767B2 (en) 2024-01-01
IL272767B1 (en) 2023-09-01
FR3070262A1 (en) 2019-03-01
EP3672607B1 (en) 2022-10-26
WO2019038411A1 (en) 2019-02-28
EP3672607A1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
EP3725798A4 (en) Bioactive conjugate, preparation method therefor and use thereof
IL275055A (en) Triabody, preparation method and use thereof
IL272767B1 (en) Composition comprising wharton's jelly, method for preparing same and uses thereof
EP3719127A4 (en) Nucleic acid, composition and conjugate containing same, preparation method, and use
EP3719126A4 (en) Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
DK3657954T3 (en) Non-hydrogenated fat composition, use and process
HK1243957B (en) Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and application thereof
EP3718572A4 (en) Nucleic acid, composition and conjugate containing nucleic acid, preparation method and use
EP3719125A4 (en) Nucleic acid, composition and conjugate containing same, and preparation method and use
PT3580208T (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
EP3594312A4 (en) Composition, method for producing same, and use thereof
EP3139941A4 (en) Tea composition comprising cyclocarya paliurus and preparation method and uses thereof
EP3733650A4 (en) Method for preparing elagolix intermediate and composition thereof
EP3284826A4 (en) Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
GB201904104D0 (en) Composition, method and use
EP3536159A4 (en) Chocolate composition having improved processability, and preparation method therefor
IL276244A (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
SG11202110871UA (en) Dmso-free cryopreservation solution and preparation method and use thereof
EP3653603A4 (en) Fenlean (flz) crystal g form, preparation method, and composition and use thereof
GB2564511B (en) Composition, method and use
GB201805016D0 (en) Composition, method and use
GB201705124D0 (en) Composition, method and use
SG10201603101YA (en) Lubricant composition, and preparation method and use thereof
EP3653601A4 (en) Fenlean (flz) crystal b form, preparation method, and composition and use thereof
GB2568928B (en) Neuroprotective composition, preparation process thereof and medical uses thereof